The primary objective of the study is to demonstrate non-inferiority of Restylane Lyft with Lidocaine versus a comparator-control for augmentation of the chin region to improve the chin profile.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
174
hyaluronic acid
hyaluronic acid
Galderma Research Site
Los Angeles, California, United States
United States, California
Manhattan Beach, California, United States
Galderma Research Site
Westport, Connecticut, United States
Primary Effectiveness Objective
Change from Baseline in the Blinded Evaluators' live assessment using the GCRS (Galderma Chin Retrusion Scale).
Time frame: 3 months after last treatment
Secondary Effectiveness Objective
Responder rate based on the Blinded Evaluator's live assessment using the GCRS (Galderma Chin Retrusion Scale) at 6, 9, and 12 months after last treatment.
Time frame: 6, 9, and 12 months after last treatment.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Galderma Research Site
Aventura, Florida, United States
Galderma Research Site
Coral Gables, Florida, United States
Galderma Research Site
Alpharetta, Georgia, United States
Galderma Research Site
Atlanta, Georgia, United States
Galderma Research Site
Rockville, Maryland, United States
Galderma Research Site
Chestnut Hill, Massachusetts, United States
Galderma Research Site
Nashville, Tennessee, United States
...and 2 more locations